ATE463478T1 - Diaryletherderivat, dessen additionssalz und immunosuppressivum - Google Patents
Diaryletherderivat, dessen additionssalz und immunosuppressivumInfo
- Publication number
- ATE463478T1 ATE463478T1 AT02768056T AT02768056T ATE463478T1 AT E463478 T1 ATE463478 T1 AT E463478T1 AT 02768056 T AT02768056 T AT 02768056T AT 02768056 T AT02768056 T AT 02768056T AT E463478 T1 ATE463478 T1 AT E463478T1
- Authority
- AT
- Austria
- Prior art keywords
- immunosuppressant
- addition salt
- diaryl ether
- ether derivative
- diaryl
- Prior art date
Links
- 150000001987 diarylethers Chemical class 0.000 title abstract 2
- 229960003444 immunosuppressant agent Drugs 0.000 title 1
- 230000001861 immunosuppressant effect Effects 0.000 title 1
- 239000003018 immunosuppressive agent Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 abstract 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Otolaryngology (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001297400 | 2001-09-27 | ||
| JP2002216191 | 2002-07-25 | ||
| PCT/JP2002/009864 WO2003029184A1 (en) | 2001-09-27 | 2002-09-25 | Diaryl ether derivative, addition salt thereof, and immunosuppressant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE463478T1 true ATE463478T1 (de) | 2010-04-15 |
Family
ID=26623110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02768056T ATE463478T1 (de) | 2001-09-27 | 2002-09-25 | Diaryletherderivat, dessen additionssalz und immunosuppressivum |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6963012B2 (de) |
| EP (1) | EP1431275B1 (de) |
| JP (1) | JP4152884B2 (de) |
| AT (1) | ATE463478T1 (de) |
| CA (1) | CA2460640C (de) |
| DE (1) | DE60235900D1 (de) |
| WO (1) | WO2003029184A1 (de) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2461212C (en) * | 2001-09-27 | 2010-08-17 | Kyorin Pharmaceutical Co., Ltd. | Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same |
| DK1471054T3 (da) * | 2002-01-11 | 2009-11-09 | Daiichi Sankyo Co Ltd | Aminoalkohol-derivat eller phosphonsyre-derivat og medicinsk sammensætning, der indeholder disse |
| PT1505959E (pt) | 2002-05-16 | 2009-02-05 | Novartis Ag | Utilização de agentes de ligação do receptor edg em cancro |
| JP4571497B2 (ja) * | 2002-09-19 | 2010-10-27 | 杏林製薬株式会社 | アミノアルコール誘導体とその付加塩及び免疫抑制剤 |
| EP1575576A2 (de) | 2002-09-24 | 2005-09-21 | Novartis AG | Organische verbindungen |
| PE20130200A1 (es) * | 2003-04-08 | 2013-03-09 | Novartis Ag | Composicion farmaceutica que contiene un agonista del receptor s1p y un alcohol de azucar |
| CN1777575B (zh) * | 2003-04-30 | 2010-05-12 | 诺瓦提斯公司 | 作为1-磷酸-鞘氨醇受体调节剂的氨基-丙醇衍生物 |
| GB0320638D0 (en) | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
| GB0324210D0 (en) | 2003-10-15 | 2003-11-19 | Novartis Ag | Organic compounds |
| GB0329498D0 (en) * | 2003-12-19 | 2004-01-28 | Novartis Ag | Organic compounds |
| TW200526548A (en) * | 2003-12-25 | 2005-08-16 | Sankyo Co | Ether derivatives |
| GB0500020D0 (en) | 2005-01-04 | 2005-02-09 | Novartis Ag | Organic compounds |
| NZ549162A (en) | 2004-02-24 | 2009-12-24 | Sankyo Co | Amino-pyrrol alcohol compounds |
| AU2005237254B2 (en) | 2004-05-03 | 2010-02-04 | Novartis Ag | Combinations comprising a S1P receptor agonist and a JAK3 kinase inhibitor |
| US7781617B2 (en) * | 2004-07-16 | 2010-08-24 | Kyorin Pharmaceutical Co., Ltd | Effective use method of medicaments and method of preventing expression of side effect |
| TW200611687A (en) * | 2004-07-29 | 2006-04-16 | Sankyo Co | Pharmaceutical compositions used for immunosuppressant |
| PL1773307T3 (pl) | 2004-07-30 | 2015-03-31 | Novartis Ag | Preparaty 2-amino-1,3-propanodioli i ich analogów |
| EP1806338B1 (de) | 2004-10-12 | 2016-01-20 | Kyorin Pharmaceutical Co., Ltd. | Verfahren zur herstellung von 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorphenyl[ethyl]-1,3-propandiolhydrochlorid und hydraten davon, und zwischenprodukte in deren herstellung |
| KR20070085465A (ko) | 2004-11-29 | 2007-08-27 | 노파르티스 아게 | Ｓ１ｐ 수용체 효능제의 투여 용법 |
| GB0504544D0 (en) | 2005-03-04 | 2005-04-13 | Novartis Ag | Organic compounds |
| TWI418350B (zh) * | 2005-06-24 | 2013-12-11 | Sankyo Co | 含有ｐｐａｒ調節劑之醫藥組成物的用途 |
| AR057455A1 (es) * | 2005-07-22 | 2007-12-05 | Merck & Co Inc | Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica |
| GT200600350A (es) * | 2005-08-09 | 2007-03-28 | Formulaciones líquidas | |
| ES2529724T3 (es) * | 2005-09-09 | 2015-02-25 | Novartis Ag | Tratamiento de enfermedades autoinmunes |
| PL1932522T3 (pl) * | 2005-10-07 | 2012-09-28 | Kyorin Seiyaku Kk | Środek terapeutyczny do leczenia choroby wątroby zawierający jako składnik czynny pochodną 2-amino-1,3-propanodiolu |
| TWI389683B (zh) * | 2006-02-06 | 2013-03-21 | Kyorin Seiyaku Kk | A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient |
| EP2007789B1 (de) | 2006-04-11 | 2015-05-20 | Novartis AG | Spirozyklische HCV/HIV-Hemmer und ihre Verwendung |
| WO2007126042A1 (ja) | 2006-04-28 | 2007-11-08 | Mitsubishi Tanabe Pharma Corporation | ２－アミノブタノール化合物及びその医薬用途 |
| TW200815600A (en) | 2006-08-04 | 2008-04-01 | Daiichi Sankyo Co Ltd | An enzyme for phosphorizing a medicine |
| CA2659598A1 (en) | 2006-08-08 | 2008-02-14 | Kyorin Pharmaceutical Co., Ltd. | Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| JP5140593B2 (ja) | 2006-08-08 | 2013-02-06 | 杏林製薬株式会社 | アミノアルコール誘導体及びそれらを有効成分とする免疫抑制剤 |
| JP5341754B2 (ja) | 2007-06-14 | 2013-11-13 | 田辺三菱製薬株式会社 | アミン化合物及びその医薬用途 |
| EP3733161A1 (de) | 2007-10-12 | 2020-11-04 | Novartis AG | Zusammensetzung mit sphingosin-1-phosphat (s1p)-rezeptormodulatoren |
| US7816435B2 (en) | 2007-10-31 | 2010-10-19 | Momentive Performance Materials Inc. | Halo-functional silane, process for its preparation, rubber composition containing same and articles manufactured therefrom |
| TW200946105A (en) | 2008-02-07 | 2009-11-16 | Kyorin Seiyaku Kk | Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient |
| PL2278960T5 (pl) | 2008-03-17 | 2020-06-29 | Actelion Pharmaceuticals Ltd. | Schemat dawkowania dla selektywnego agonisty receptora sip1 |
| WO2009142194A1 (ja) * | 2008-05-19 | 2009-11-26 | 杏林製薬株式会社 | 光学活性アミノアルコール誘導体の製造方法 |
| CA2724592A1 (en) | 2008-05-20 | 2009-11-26 | Kyorin Pharmaceutical Co., Ltd. | Agent for maintenance of induced remission |
| GB0901835D0 (en) | 2009-02-04 | 2009-03-11 | Syngenta Ltd | Novel herbicides |
| GB0901834D0 (en) | 2009-02-04 | 2009-03-11 | Syngenta Ltd | Novel herbicides |
| US20110182850A1 (en) | 2009-04-10 | 2011-07-28 | Trixi Brandl | Organic compounds and their uses |
| US8512690B2 (en) | 2009-04-10 | 2013-08-20 | Novartis Ag | Derivatised proline containing peptide compounds as protease inhibitors |
| HRP20141065T1 (hr) | 2009-07-09 | 2015-02-13 | Kyorin Pharmaceutical Co., Ltd. | Derivati difenil-sulfida i lijekovi koji ih sadrže kao aktivni sastojak |
| KR101148098B1 (ko) | 2010-04-30 | 2012-05-22 | 한국화학연구원 | 1-［4-（4-니트로-페녹시）-페닐］-프로판-1-온을 유효성분으로 함유하는 톡소포자충 및 콕시디움에 기인한 질환의 예방 및 치료용 조성물 |
| KR20130066630A (ko) * | 2010-05-06 | 2013-06-20 | 노파르티스 아게 | 자가면역 질환의 치료 |
| BR112012028248A2 (pt) | 2010-05-06 | 2016-08-02 | Novartis Ag | derivados de sulfeto de diarila, seu uso, e kit |
| JP5909495B2 (ja) | 2010-10-08 | 2016-04-26 | ノバルティス アーゲー | スルファミドｎｓ３阻害剤のビタミンｅ製剤 |
| TWI519539B (zh) | 2010-12-21 | 2016-02-01 | Kyorin Seiyaku Kk | Diphenyl sulfide derivatives and pharmaceuticals as an active ingredient thereof |
| CN102863345A (zh) * | 2011-07-06 | 2013-01-09 | 中国医学科学院药物研究所 | 胺基丙二醇类衍生物、其制备方法和其药物组合物与用途 |
| DK2731935T3 (en) * | 2011-07-13 | 2016-06-06 | Basf Agro Bv | FUNGICIDE SUBSTITUTED 2- [2-HALOGENALKYL-4- (PHENOXY) -PHENYL] -1- [1,2,4] TRIAZOL-1-YLETHANOL COMPOUNDS |
| EA201400137A1 (ru) | 2011-07-15 | 2014-06-30 | Басф Се | Фунгицидные алкилзамещенные 2-[2-хлоро-4-(4-хлорофенокси)фенил]-1-[1,2,4]триазол-1-ил-этанольные соединения |
| EP2731934A1 (de) | 2011-07-15 | 2014-05-21 | Basf Se | Fungizide alkyl- und arylsubstituierte 2-[2-chlor-4-(dihalo-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanolverbindungen |
| CN103717577B (zh) | 2011-08-15 | 2016-06-15 | 巴斯夫欧洲公司 | 杀真菌的取代的1-{2-环基氧基-2-[2-卤代-4-(4-卤代苯氧基)苯基]乙基}-1h-[1,2,4]三唑化合物 |
| AR087538A1 (es) | 2011-08-15 | 2014-04-03 | Basf Se | Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-alcoxi-2-alquinil/alquenil-etil}-1h-[1,2,4]triazol sustituidos |
| EP2744791B1 (de) | 2011-08-15 | 2015-10-28 | Basf Se | Fungizide substituierte 1-{2-[2-halo-4-(4-halogen-phenoxy-)phenyl-]2-alkoxy-3-methyl-butyl}-1h-[1,2,4-]triazol-verbindungen |
| JP6194306B2 (ja) | 2012-04-23 | 2017-09-06 | 田辺三菱製薬株式会社 | アミン化合物及びその医薬用途 |
| EA030875B1 (ru) | 2012-12-20 | 2018-10-31 | Басф Агро Б.В. | Композиции, содержащие триазольное соединение |
| CA2895256C (en) | 2013-01-09 | 2021-06-01 | BASF Agro B.V. | Process for the preparation of substituted oxiranes and triazoles |
| CN106028817A (zh) | 2013-07-08 | 2016-10-12 | 巴斯夫农业公司 | 包含三唑化合物和生物农药的组合物 |
| CN104844486B (zh) * | 2014-02-17 | 2018-10-30 | 中国医学科学院药物研究所 | 胺基丙二醇类衍生物、其制备方法和其药物组合物与用途 |
| EA201892682A1 (ru) | 2014-06-25 | 2019-04-30 | Басф Агро Б.В. | Пестицидные композиции |
| UA120628C2 (uk) | 2014-11-07 | 2020-01-10 | Басф Се | Пестицидні суміші |
| CA3015456C (en) | 2016-03-16 | 2024-09-17 | Basf Se | USE OF TETRAZOLINONES TO CONTROL RESISTANT PLANT PATHOGENIC FUNGI ON FRUIT |
| ES3056157T3 (en) | 2016-03-16 | 2026-02-18 | Basf Se | Use of a specific tetrazolinone for combating resistant phytopathogenic fungi on cereals |
| US11241012B2 (en) | 2016-03-16 | 2022-02-08 | Basf Se | Use of tetrazolinones for combating resistant phytopathogenic fungi on soybean |
| IL280451B2 (en) | 2018-07-27 | 2025-10-01 | Priothera Ltd | A preparation for preventing recurrence of proliferative blood disease in patients who have undergone hematopoietic stem cell transplantation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69321823T2 (de) * | 1992-10-21 | 1999-06-02 | Taito Co., Ltd., Tokio/Tokyo | 2-amino-1, 3- propandiolverbindung und immunosuppressium |
| EP0778263B1 (de) * | 1994-08-22 | 2002-01-09 | Welfide Corporation | Benzolderivate und deren medizinische verwendung |
| ES2240868T3 (es) * | 1997-04-04 | 2005-10-16 | Mitsubishi Pharma Corporation | Compuesto de 2-aminopropano -1,3-diol, su uso farmaceutico e intermedios en su sintesis. |
-
2002
- 2002-09-25 DE DE60235900T patent/DE60235900D1/de not_active Expired - Lifetime
- 2002-09-25 JP JP2003532439A patent/JP4152884B2/ja not_active Expired - Fee Related
- 2002-09-25 US US10/490,345 patent/US6963012B2/en not_active Expired - Fee Related
- 2002-09-25 AT AT02768056T patent/ATE463478T1/de not_active IP Right Cessation
- 2002-09-25 EP EP02768056A patent/EP1431275B1/de not_active Expired - Lifetime
- 2002-09-25 WO PCT/JP2002/009864 patent/WO2003029184A1/ja not_active Ceased
- 2002-09-25 CA CA2460640A patent/CA2460640C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20040242654A1 (en) | 2004-12-02 |
| US6963012B2 (en) | 2005-11-08 |
| DE60235900D1 (de) | 2010-05-20 |
| JPWO2003029184A1 (ja) | 2005-01-13 |
| EP1431275A1 (de) | 2004-06-23 |
| JP4152884B2 (ja) | 2008-09-17 |
| EP1431275A4 (de) | 2006-05-31 |
| CA2460640A1 (en) | 2003-04-10 |
| WO2003029184A1 (en) | 2003-04-10 |
| CA2460640C (en) | 2011-03-29 |
| EP1431275B1 (de) | 2010-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE463478T1 (de) | Diaryletherderivat, dessen additionssalz und immunosuppressivum | |
| CY1107272T1 (el) | Παραγωγο διαρυλ σουλφιδιου, αλας προσθηκης εξ αυτου και ανοσοκατασταλτικο | |
| EA200100411A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
| ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
| PT1453512E (pt) | Derivados de acetileno tendo actividade antagonistica do mglur 5 | |
| TR199901473T2 (xx) | Ha�ere �ld�r�c� 1-arilpirazoller | |
| DE69718194D1 (de) | Amidinophenyl-pyrrolidine, -pyrroline und -isoxazolidine und ihre derivate | |
| ID18883A (id) | Pesaing 5-ht 1f | |
| DE69418704D1 (de) | Anthranilsäure derivate | |
| DK0618190T3 (da) | 9-(Substitueret glycyl)amido-6-(substitueret)-5-hydroxy-6-deoxy-tetracycliner | |
| ATE248824T1 (de) | Substituierte phenylderivate, ihre herstellung und verwendung | |
| PT897904E (pt) | 2-metoxibenzofenonas fungicidas | |
| DE69716925D1 (de) | Isoxazoline derivate und ihre verwendung als antimikroben | |
| TR200102338T2 (tr) | Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar. | |
| CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
| PT718293E (pt) | Composto ciclodepsipeptidico | |
| DE60116589D1 (de) | Fungizide Phenylamidinderivative | |
| MY136297A (en) | Piperazine derivatives having sst1 antagonistic activity | |
| AU2002357740A1 (en) | Pyrazolo-pyridine derivatives as antiherpes agents | |
| DE69912193D1 (de) | Substituierte 2-Hydroxybenzophenone, ihre Herstellung, ihre Verwendung als fungizide und ihre fungizide Zusammensetzungen | |
| DE60108209D1 (de) | Fungizide Phenylimidate-Derivate | |
| DK1328275T3 (da) | Substituerede 4,5-dihydro-1,2,4-triazin-3-oner, 1,2,4-triazin-3-oner og deres anvendelse som fungicider og insekticider | |
| ATE321760T1 (de) | N-aryl-2-oxazolidinone und deren derivate | |
| DK0539326T3 (da) | Bis(phenyl)ethanderivater | |
| BRPI0413744A (pt) | n-aril-2-ciano-oxazolidinonas e seus derivados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |